Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Ethernity secures $1.05m licence agreement

(Sharecast News) - Data processing semiconductor technology specialist Ethernity Networks announced on Friday that it had secured a $1.05m licence agreement with a new tier one US-based aerospace system products provider. The AIM-traded firm said the majority of the project was expected to be delivered in the second half of 2024.

It said the agreement would see it delivering its silicon-tuned software to enable specific networking functionalities on a field-programmable gate array (FPGA) device for the customer's platform.

The company said it believed the collaboration had the potential to lead to further discussions in 2024 and 2025, potentially increasing the deal's value.

The project's implementation and development, based on Ethernity's ENET data flow processor, remained conditional on US government approval, which was expected by August.

Similar approvals had been granted to Ethernity's previous aerospace customers in the US.

"We are excited to partner with this prestigious aerospace Customer to empower their next-generation solutions," said chief executive officer David Levi.

"We are committed to delivering exceptional value and exceeding their expectations throughout this collaboration."

At 1501 BST, shares in Ethernity Networks were up 35.17% at 0.98p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Mirriad flags weaker first-half revenue
(Sharecast News) - Virtual product placement and in-content advertising specialist Mirriad said in an update on Friday that it expected revenue for the first half to be around £0.4m, down from £0.59m in the first six months of the 2023 financial year.
European drugs body backs Moderna jab
(Sharecast News) - Europe's drug regulator has backed Moderna's novel vaccine for respiratory syncytial virus, the US pharmaceutical firm announced on Friday.
Symphony reports consistent trading as it works to accelerate projects
(Sharecast News) - Symphony Environmental Technologies said in an update on Friday that its trading remained consistent with recent statements.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.